Co-Diagnostics, Inc. Contracts & Agreements

Commercial Lease Agreement, dated June 1, 2023, between Ozone Biotech, LLC and Co-Diagnostics, Inc (Filed With SEC on August 10, 2023)

Co-Diagnostics, Inc. Change in Control Severance Plan (Filed With SEC on May 16, 2023)

Amendment to Agreement and Plan of Merger by and among Co-Diagnostics, Inc., Advanced Conceptions, Inc., and Richard Abbott, as Company Representative (Filed With SEC on June 16, 2022)

Amendment to Agreement and Plan of Merger by and among Co-Diagnostics, Inc., Idaho Molecular, Inc., and Kirk Ririe, as Company Representative (Filed With SEC on June 16, 2022)

Description of Registrants securities (Filed With SEC on March 24, 2022)

Warrant Agreement between Co-Diagnostics, Inc and VStock Transfer, LLC. Dated December 31, 2021 (ACI Warrant) (Filed With SEC on March 24, 2022)

Warrant Agreement between Co-Diagnostics, Inc and VStock Transfer, LLC. Dated December 31, 2021 (IDMO Warrant) (Filed With SEC on March 24, 2022)

Lease Agreement 2401 Foothill Drive (Filed With SEC on March 24, 2022)

Amendment #1 to Lease (Filed With SEC on March 24, 2022)

Amendment #2 to Lease (Filed With SEC on March 24, 2022)

Agreement and Plan of Merger by and between Co-Diagnostics, Inc, IDMO Acquisition Corp., Idaho Molecular Inc., and Company Representative dated as of December 21, 2021 (Filed With SEC on December 23, 2021)

Agreement and Plan of Merger by and between Co-Diagnostics, Inc, ACI Acquisition Corp., Advanced Conceptions, Inc., and Company Representative dated as of December 21, 2021 (Filed With SEC on December 23, 2021)

Description of Registrants securities (Filed With SEC on March 25, 2021)

Form of Securities Purchase Agreement, dated February 27, 2020 (Filed With SEC on February 27, 2020)

Form of Securities Purchase Agreement, dated February 10, 2020 (Filed With SEC on February 11, 2020)

Form of Securities Purchase Agreement, dated January 23, 2020 (Filed With SEC on January 27, 2020)

Form of Second Amendment Agreement (Filed With SEC on April 1, 2019)

Form of Securities Purchase Agreement, dated January 31, 2019, for the Common Stock (Filed With SEC on February 4, 2019)

Form of Securities Purchase Agreement, dated January 30, 2019, for the Preferred Stock (Filed With SEC on February 4, 2019)

9% Promissory Note, dated August 3, 2018, between Co-Diagnostics, Inc. and Robert Salna for $2,000,000 (Filed With SEC on August 9, 2018)

Underwriting Agreement dated July 12, 2017 (Filed With SEC on July 13, 2017)

Form of Second Amendment Agreement (Filed With SEC on July 10, 2017)

Form of Amendment Agreement (Filed With SEC on June 23, 2017)

UNDERWRITING AGREEMENT among CO-DIAGNOSTICS, INC. and WALLACHBETH Capital, LLC and NETWORK 1 FINANCIAL SECURITIES, INC., as Representatives of the Several Underwriters (Filed With SEC on June 9, 2017)

Underwriting Agreement (Filed With SEC on May 24, 2017)

Form of Indemnification Agreement (Filed With SEC on May 24, 2017)

Form Second Amendment to 12% Revolving Line of Credit Promissory Note Due 2017 between Co-Diagnostics, Inc. and Turks and Caicos Limited Company, Pine Valle Investments, LLC,... (Filed With SEC on May 24, 2017)

8.5% CONVERTIBLE NOTE DUE 2017 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)

CO-DIAGNOSTICS, INC. 2015 LONG TERM INCENTIVE PLAN 1. GENERAL (Filed With SEC on April 28, 2017)

CO-DIAGNOSTICS, INC. PROSPERITY INVESTMENTS SUBSCRIPTION AGREEMENT (Filed With SEC on April 28, 2017)

MUTUAL RESCISSION AGREEMENT (Filed With SEC on April 28, 2017)

NON-INTEREST BEARING NOTE DUE 2020 (Filed With SEC on April 28, 2017)

STOCK PURCHASE AGREEMENT (Filed With SEC on April 28, 2017)

AMENDED EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on April 28, 2017)

SHAREHOLDERS AGREEMENT (Filed With SEC on April 28, 2017)

10% CONVERTIBLE NOTE DUE 2017 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)

12% CONVERTIBLE NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)

AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROMISSORY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)

AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROMISSOPRY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)

AMENDMENT TO 12% PROMISSOPRY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)

AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROMISSOPRY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)

AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROIVIISSOPRY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)

REVOLVING LINE OF CREDIT PROMISSORY NOTE (Filed With SEC on April 28, 2017)